Kongressthemen Now in its 11th year, World ADC Europe prides itself in being the industry-leading conference to help forward thinking researchers from the pharmaceutical, biotech and academic community advance the development of antibody-drug conjugates.
Since the last World ADC London in March of 2020, we have seen huge progress within the ADC field with the approval of Trodelvy from Immunomedics, Blenrep from GSK - and now with ADC Therapeutics submitting their BLA in September of 2020.
Speakers: Adam Taylor, Scientist, Defence Science and Technology Laboratory - DSTL, Agnieska Czechowicz, Assistant Professor of Pediatrics, Stanford University School of Medicine, and more.
